Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue
Analysing the regeneration of T lymphocytes after high-dose chemotherapy with autologous peripheral blood progenitor cell rescue (PBPCR) may help elucidate the mechanisms of immune recovery. The T-cell receptor variable beta chain (TCRBV) repertoire of adult patients undergoing high-dose chemotherapy was analysed by flow cytometry, before and after treatment. Four patients were found to have a stable expansion present (TCRBV3, 17, 21 and 22) ranging from 8% to 42% of the CD4(+) or CD8(+) repertoire. We demonstrated that, in these patients, following high-dose chemotherapy and autologous stem cell transplantation, the clonal expansions reappeared in peripheral blood and returned to pretransplant levels. Three expansions (CD3(+)CD8(+)TCRBV3(+), CD3(+)CD4(+)TCRBV21(+) and CD3(+)CD8(+)TCRBV22(+)) were further defined by sequence analysis of the complementarity-determining region (CDR)3 portion within the TCR rearrangements. These were shown to be predominantly clonal, with the same sequences being identified in peripheral blood before and after PBPCR, providing evidence that the overwhelming majority of T cells in these expansions arise from mature lymphocytes. This study demonstrated that patients undergoing autologous PBPCR for high-dose chemotherapy regenerate clonal expansions, consistent with pretreatment levels. They also regenerate T-cell repertoires with each TCRBV family represented to a similar level as that prior to high-dose chemotherapy.
766-773
Protheroe, A.S.
81965b1c-8b45-4482-b623-bc70a02f4ed5
Pickard, C.
e21117b3-6345-4d09-a876-ac9965ec4d6a
Johnson, Peter W.M.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Craddock, T.
9ebd6e37-41bd-4d76-9655-f784100ef908
Shefta, J.
bd21ae40-47fb-471c-8fad-6a5fd798f5bd
Short, K.
5ba61192-8f2d-4f43-917a-c1b2d097d1fb
Lancaster, F.
a51ae4f1-e618-4bc2-9b17-0173adc6e838
Selby, P. J.
72d562a6-a9ec-45c6-bff8-f4defa60de68
Henwood, J.
bf12f16e-b568-4463-b246-4da30a4b89ee
Boylston, A.W.
66264d98-a57c-4f11-babe-d76930926985
December 2000
Protheroe, A.S.
81965b1c-8b45-4482-b623-bc70a02f4ed5
Pickard, C.
e21117b3-6345-4d09-a876-ac9965ec4d6a
Johnson, Peter W.M.
3f6068ce-171e-4c2c-aca9-dc9b6a37413f
Craddock, T.
9ebd6e37-41bd-4d76-9655-f784100ef908
Shefta, J.
bd21ae40-47fb-471c-8fad-6a5fd798f5bd
Short, K.
5ba61192-8f2d-4f43-917a-c1b2d097d1fb
Lancaster, F.
a51ae4f1-e618-4bc2-9b17-0173adc6e838
Selby, P. J.
72d562a6-a9ec-45c6-bff8-f4defa60de68
Henwood, J.
bf12f16e-b568-4463-b246-4da30a4b89ee
Boylston, A.W.
66264d98-a57c-4f11-babe-d76930926985
Protheroe, A.S., Pickard, C., Johnson, Peter W.M., Craddock, T., Shefta, J., Short, K., Lancaster, F., Selby, P. J., Henwood, J. and Boylston, A.W.
(2000)
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue.
British Journal of Haematology, 111 (3), .
Abstract
Analysing the regeneration of T lymphocytes after high-dose chemotherapy with autologous peripheral blood progenitor cell rescue (PBPCR) may help elucidate the mechanisms of immune recovery. The T-cell receptor variable beta chain (TCRBV) repertoire of adult patients undergoing high-dose chemotherapy was analysed by flow cytometry, before and after treatment. Four patients were found to have a stable expansion present (TCRBV3, 17, 21 and 22) ranging from 8% to 42% of the CD4(+) or CD8(+) repertoire. We demonstrated that, in these patients, following high-dose chemotherapy and autologous stem cell transplantation, the clonal expansions reappeared in peripheral blood and returned to pretransplant levels. Three expansions (CD3(+)CD8(+)TCRBV3(+), CD3(+)CD4(+)TCRBV21(+) and CD3(+)CD8(+)TCRBV22(+)) were further defined by sequence analysis of the complementarity-determining region (CDR)3 portion within the TCR rearrangements. These were shown to be predominantly clonal, with the same sequences being identified in peripheral blood before and after PBPCR, providing evidence that the overwhelming majority of T cells in these expansions arise from mature lymphocytes. This study demonstrated that patients undergoing autologous PBPCR for high-dose chemotherapy regenerate clonal expansions, consistent with pretreatment levels. They also regenerate T-cell repertoires with each TCRBV family represented to a similar level as that prior to high-dose chemotherapy.
This record has no associated files available for download.
More information
Published date: December 2000
Identifiers
Local EPrints ID: 157843
URI: http://eprints.soton.ac.uk/id/eprint/157843
ISSN: 0007-1048
PURE UUID: 1beb1862-bad4-4164-8e32-ebde91313765
Catalogue record
Date deposited: 16 Jun 2010 12:26
Last modified: 09 Jan 2022 02:56
Export record
Contributors
Author:
A.S. Protheroe
Author:
C. Pickard
Author:
T. Craddock
Author:
J. Shefta
Author:
K. Short
Author:
F. Lancaster
Author:
P. J. Selby
Author:
J. Henwood
Author:
A.W. Boylston
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics